John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), sold 75,466 shares at $1.52 ($115K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Open-market sale of $115k AKBA by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.52 | 37,733 | $57K | 50.0% |
| 2 | $1.52 | 37,733 | $57K | 50.0% |
| Total | $1.52 avg | 75,466 | $115K | 100% |
| Filing → |
| AKBA | SELL | 2025-03-04 | $170K | — | Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |